Please use this identifier to cite or link to this item:
|Title:||Moderate alcohol use in fatty liver disease; don't throw the cabernet out with the bathwater.|
|Authors:||Gow, Paul J;Testro, Adam G;Hey, Penelope;Sinclair, Marie|
|Affiliation:||Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia|
The University of Melbourne, Victoria, Australia
|Citation:||Hepatology (Baltimore, Md.) 2019; online first: 29 November|
|Abstract:||We congratulate Dr Aberg and colleagues for a significant contribution to the literature on the important topic of moderate alcohol use in fatty liver disease (NAFLD) (1). Approximately 30% of the population of the Western world has obesity and/or other complications of insulin resistance and the metabolic syndrome. Due to the magnitude of this problem worldwide, palatable lifestyle therapies that are affordable, available and acceptable are necessary to curtail preventable early deaths. Moderate alcohol has the potential to fill this space, although knowledge remains limited.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.